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HindbrainBilateral injections of moxonidine, an α2-adrenoceptor and imidazoline receptor agonist, into the lateral
parabrachial nuclei (LPBN) enhance sodium appetite induced by extracellular dehydration. In the present
study, we examined whether LPBN moxonidine treatments change taste reactivity to hypertonic NaCl
solution administered into the mouth by intra-oral (IO) cannula. Male Holtzman rats prepared with IO and
bilateral LPBN cannulas received subcutaneous injections of furosemide (FURO; 10 mg/kg) and captopril
(CAP; 5 mg/kg) to induce hypovolemia with mild hypotension and an accompanying salt appetite and thirst
before testing the taste reactivity to oral infusions of 0.3 M NaCl (1.0 ml/min). In the ﬁrst experiment 45 min
after subcutaneous injections of FURO+CAP or vehicle, moxonidine was bilaterally injected into the LPBN,
and then 15 min later both bodily and oral–facial ingestive and rejection responses to 0.3 M NaCl delivered
through the IO cannula were assessed. Both LPBN vehicle and moxonidine treated rats showed increased
ingestive and decreased rejection responses to the IO hypertonic solution. The IO 0.3 M NaCl infusion-evoked
ingestive and rejection taste related behaviors were comparable in the LPBN vehicle- vs. the LPBN
moxonidine-injected groups. In a second experiment, rats received the same FURO+CAP treatments and
LPBN injections. However, beginning 15 min after the LPBN injections, they were given access to water and
0.3 M NaCl and were allowed to consume the ﬂuids for most of the next 60 min with the free access intake
being interrupted only for a fewminutes at 15, 30 and 60 min after the ﬂuids became available. During each of
these three brief periods, a taste reactivity test was conducted. On the three taste reactivity tests rats that
received LPBN vehicle injections showed progressive declines in ingestive responses and gradual increases in
rejection responses. However, in contrast to the LPBN vehicle treated rats, animals receiving bilateral
injections of LPBN moxonidine maintained a high number of ingestive responses and a low number of
rejection responses throughout the test period even in spite of evidencing substantial water and 0.3 M NaCl
consumption during the periods of free access. The results suggest that afterα2-adrenoceptor agonist delivery
to the LPBN the acceptance of 0.3 M NaCl is sustained and the negative attributes of the solution are
minimized. The maintained positive rewarding qualities of 0.3 M NaCl are likely to account for why LPBN
moxonidine treated rats show such a remarkable salt appetite when assayed by the volume of hypertonic
0.3 M NaCl consumed.logy, Institute of Biomedical
130-000, Alfenas, MG, Brazil.
ndrade@yahoo.com
Elsevier OA license.© 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Sodium chloride (NaCl) is an important constituent of the
extracellular ﬂuid compartment and the major determinant of plasma
osmolality and extracellular ﬂuid volume. The acquisition and
ingestion of water and of salty substances are necessary behavioral
responses for an animal to recover from deﬁcits in body ﬂuids. Sodium
deﬁciency results in behaviors collectively known as sodium appetite
(a.k.a. salt appetite) and which can be operationally deﬁned by an
703C.A.F. Andrade et al. / Physiology & Behavior 104 (2011) 702–708increased ingestion of sodium solutions of concentrations which are
normally avoided [1–3].
In the hindbrain, important inhibitory mechanisms for the control
of water and NaCl intake have been demonstrated in the lateral
parabrachial nucleus (LPBN) [4–10]. The LPBN, a pontine structure
that lies dorsolateral to the superior cerebellar peduncle, is recipro-
cally connected to forebrain areas that have been implicated in the
maintenance of blood pressure and body ﬂuid homeostasis, such as
the paraventricular nucleus of the hypothalamus, the central nucleus
of the amygdala and the median preoptic nucleus. The LPBN is also
richly interconnected with medullary regions, which include the area
postrema (AP) and the medial portion of the nucleus of the solitary
tract (mNTS), [11–18]. Cells in the LPBN are activated after ingestion
of sodium solutions by dehydrated rats or in rats that received
intragastric loads of hypertonic NaCl [19–21], suggesting that the
LPBN might receive inhibitory visceral or taste signals. Therefore, the
LPBN may integrate and relay taste and visceral signals that ascend
from AP/mNTS en route to forebrain areas involved in the control of
ﬂuid and electrolyte balance [7–9,22,23].
The inhibitory mechanisms of the LPBN are modulated by different
neurotransmitters like serotonin, cholecystokinin, glutamate, corti-
cotrophin releasing factor, opioids and noradrenaline [7–10,24–32].
Activation of α2-adrenoceptors with bilateral LPBN injections of
moxonidine (α2-adrenoceptor/imidazoline receptor agonist) or nor-
adrenaline strongly enhances 0.3 M NaCl intake induced by subcuta-
neous treatment with the diuretic furosemide (FURO) when
combined with a low dose of the antihypertensive drug, captopril
(CAP) [24,32,33]. This suggests that activation of α2-adrenoceptors in
the LPBN may reduce the effects of inhibitory mechanisms that limit
sodium intake [24,32,33]. The effects of α2-adrenoceptor agonist
treatment of the LPBN on sodium intake are not due to a non-speciﬁc
facilitation of all ingestive behaviors, because sucrose solution intake
is not affected by bilateral LPBN injections of moxonidine [33].
A taste reactivity test determining the frequency of ingestive and
rejection behavioral reactions or ﬁxed action patterns in response to
intra-orally delivered solutions was originally developed by Grill and
Norgren[34]. This method assesses the occurrences of species-typical
affective behavioral reactions [such as ingestive-related tongue
protrusions or negative (rejection) gapes] in response to oral
stimulation [34,35]. Lesions placedwithin either the NTS, parabrachial
nucleus (PBN), or the parvocellular ventral posteromedial thalamic
nucleus (VPMpc) disrupt the shift in taste reactivity observed in intact
animals after sodium deﬁciency [36]. Lesions placed in the NTS and
PBN, but not the VPMpc, also block increases in home-cage intake
observed in intact, sodium deﬁcient rats [36].
Since α2-adrenoceptor activation with the administration of
moxonidine into the LPBN greatly increases NaCl intake in free access
intake tests, the present studies tested whether LPBN α2-adrenoceptor
stimulationmodiﬁes taste reactivity responses to 0.3 MNaCl in ratswith
an experimentally-induced sodium appetite. The results of the
experiments indicate that before animals ingest 0.3 M NaCl and water,
LPBN moxonidine treatment does not increase or decrease the number
of ingestive or rejection behaviors in comparison to those seen in LPBN
vehicle treated rats. However, the ﬁndings do demonstrate that unlike
LPBN vehicle treated animals showing decreased ingestive and
increased rejection responses over the course of restoring body sodium
and water, rats receiving LPBN moxonidine maintain a high level
ingestive responses and a low number of rejection responses through-
out a period of ﬂuid repletion.
2. Material and methods
2.1. Animals
Male Holtzman rats weighing 290 to 310 g were housed in
individual stainless steel cages with free access to normal sodium(0.5–1.0%) diet (Guabi Rat Chow, Paulínia, SP, Brazil), water and 0.3 M
NaCl solution. Temperature was maintained at 23±2 °C, and
humidity was maintained at 55±10% on a 12:12 light–dark cycle
with light onset at 7:30 AM. The Ethical Committee for Animal Care
and Use from the Dentistry School of Araraquara — UNESP approved
the experimental protocols used in the present study (protocol
06/2006). The experimental protocols also followed the U.S. National
Institutes of Health Guide for the Care and Use of Laboratory Animals
(NIH publication no. 80-23, 1996).
2.2. Cerebral and IO cannulas
Rats were anesthetized with ketamine (80 mg/kg of body weight)
combined with xylazine (7 mg/kg of body weight) and placed in a
Kopf stereotaxic instrument. The skull was leveled between bregma
and lambda. Stainless steel 23-gauge cannulas were implanted
bilaterally above the LPBN using the following coordinates: 9.4 mm
caudal to bregma, 2.1 mm lateral to the midline, and 4.2 mm below
the dura mater, according to Paxinos and Watson [37]. The tips of the
cannulas were positioned at a point 2 mm above each LPBN. The
cannulas were ﬁxed to the cranium using dental acrylic resin and
jeweler screws, and 20-gauge metal obturators were used to ﬁll the
cannulas between tests. Immediately after the implantation of LPBN
cannulas, all animals were also implanted with chronic IO cannulas.
Each oral cannula (heat-ﬂared PE 50 tubing) entered the mouth just
lateral to the ﬁrst maxillary molar. The tubing was tunneled
subcutaneously to ascend lateral to the skull, and posterior to the
nape of neck where the free end was exteriorized. The IO cannulas do
not interfere with the normal eating behavior of the animal and allow
the direct infusion of solutions into the mouth. The rats were allowed
to recover for 6 days before drug injections were made into the LPBN.
2.3. Injections into the LPBN
Bilateral injections into the LPBN were made using 5-μl Hamilton
syringes connected by polyethylene tubing (PE-10) to 30-gauge
injection cannulas. At time of testing, obturators were removed and
the injection needle (2 mm longer than the guide cannulas) was
introduced in the brain. All the injections into the LPBNwere 0.2 μl for
each site and performed over a period of 1 min, with 1 additional min
allowed to elapse before the injection needle was removed from the
guide cannula to avoid reﬂux. The movement of an air bubble inside
the polyethylene tubing connected to the syringe conﬁrmed drug
ﬂow. The obturators were replaced after injection, and the rats were
placed back into the cage.
2.4. Drugs
Moxonidine hydrochloride (0.5 nmol/0.2 μl) (Solvay Pharma,
Hannover, Germany) dissolved in a mix of propylene glycol and
water 2:1 (vehicle) was injected into the LPBN. Vehicle was injected
as control.
The natriuretic/diuretic drug FURO (10 mg/ml; Sigma Chem., St
Louis, MO, USA) was dissolved in alkaline saline (0.9% NaCl, pH was
adjusted to9.0withNaOH)andadministered s.c. at thedoseof 10 mg/kg
of body weight. The angiotensin converting enzyme inhibitor CAP
(5 mg/ml; Sigma Chem., St. Louis, MO, USA) was dissolved in saline
(0.9% NaCl) and administered s.c. at the dose of 5 mg/kg of body
weight. The pH 9.0 saline solution was used as the vehicle control for
FURO and normal 0.9% saline as the vehicle control for CAP.
2.5. Taste reactivity test
Prior to the testing period, rats with LPBN and IO cannulas were
each given a 3-day habituation period during which they were
exposed to the taste reactivity chamber for 10 min, followed by a 1 ml
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interval between tests.
2.5.1. Experiment 1 — taste reactivity to 0.3 M NaCl in rats treated with
sc FURO+CAP
On each test day, each rat was treated with sc FURO (10 mg/kg of
body weight)+CAP (5 mg/kg of body weight) or vehicle+saline. At
this time, water, food and 0.3 M NaCl were removed from the rat's
home cage. Forty-ﬁve minutes later, rats received bilateral injections
of moxonidine (0.5 nmol/0.2 μl) or vehicle (0.2 μl) into the LPBN.
Immediately after the LPBN injections, the rat's oral cannula was
connected to a stimulus delivery tube, consisting of PE 50 tubing
attached to an infusion pump. The rats were then placed in a
cylindrical plexiglas test chamber (30 cm diameter). Fifteen minutes
later (i.e., 1 h after FURO+CAP sc and 15 min after LPBN injections),
0.3 MNaCl was infused into themouth of the animal at a constant rate
(1.0 ml/min) for 1 min. The rats were given four tests. For each test the
rats were divided into two groups and each group received one of
the following treatments: 1) vehicle+saline (sc)+vehicle (LPBN), 2)
vehicle+saline (sc)+moxonidine (LPBN), 3) FURO+CAP (sc)+vehicle
(LPBN), and 4) FURO+CAP (sc)+moxonidine (LPBN). The sequence of
the treatments in each group was balanced, and by the end of
experiments, all animals had received all four treatments. During testing,
rats had no access to water, 0.3 M NaCl and food.
2.5.2. Experiment 2 — taste reactivity to 0.3 M NaCl in rats treated with
sc FURO+CAP combined with LPBN moxonidine injections after free
access to water and 0.3 M NaCl
The results from experiment 1 (see below) indicated that LPBN
moxonidine treatment did not enhance ingestive responses or decrease
rejection responses to IO 0.3 M NaCl in comparison to LPBN vehicle
treated rats 1 h after both groups had received FURO+CAP. Conse-
quently, a second experiment was conducted to determine if taste
reactivity remained unaltered in LPBN vehicle treated vs. LPBN
moxonidine treated rats even after periods of 0.3 M NaCl and water
consumption.
On each test day, each rat received FURO (10 mg/kg of body
weight)+CAP (5 mg/kg of body weight) treatment sc and had water,
0.3 M NaCl and food removed from the home cage. Forty-ﬁve minutes
later, rats received bilateral injections of moxonidine (0.5 nmol/0.2 μl)
or vehicle (0.2 μl) into the LPBN. Fifteen minutes after the LPBN
injections, burettes (0.1 ml subdivisions) with water and 0.3 M NaCl
were available in the rat's home cage, and the rats were allowed to
ingest both ﬂuids continuously for 60 min, except for a fewminutes at
15, 30 and 60 min after being given free access to both ﬂuids. During
each of these three brief periods, the rats were given a taste reactivity
test. During each test the rat was removed from the home cage and
placed in a taste reactivity chamber. The IO cannula of the rat was
connected to a stimulus delivery tube, consisting of PE 50 tubing
attached to an infusion pump and 0.3 M NaCl was infused into the
mouth of the animal at a constant rate (1.0 ml/min) for 1 min, while
the behavior was videotaped. At the end of each taste reactivity test,
until all three tests were completed, the rat was placed back into its
home cage, where water and 0.3 M NaCl were available, and the rat
was allowed to drink until the next taste reactivity test. Water and
0.3 M NaCl ingested was also measured at 15, 30 and 60 min after
starting the access to these ﬂuids.
The rats received 2 tests. In each test, all rats received FURO+CAP (sc)
andwere then divided into two groups. One group received LPBN vehicle
injections and the other LPBN moxonidine injections. The order of the
tests was counterbalanced so that all animals received all treatments.
2.5.3. Video recording and analysis of taste reactivity
For all protocols described above, the behavior of each rat was
videotaped during testing via a mirror mounted beneath thetransparent ﬂoor of the test chamber. The recorded image was
enlarged so the face and mouth of the rat ﬁlled the entire screen.
The behavior of each rat was scored for the occurrence of ingestive,
rejection (aversive), and “neutral” taste reactivity components (see
[35] for a description and discussion of taste reactivity analysis
components and classiﬁcation). Ingestive actions were characterized
by paw licking; lateral tongue protrusions, non-rhythmic protrusions
past the lip followed by forward extension; and tongue protrusions,
rhythmic tongue protrusions along the midline. Neutral components
were rhythmic mouth movements at the same or lower frequency as
rhythmic tongue protrusions; and passive dripping, the passive leaking
of ﬂuid from the mouth. Rejection behaviors were gapes, large
openings of the mandible and retraction of the lower lips; chin
rubbing, bringing the mouth in direct contact with the ﬂoor and
projecting the body forward; face washing, either a single wipe over
the face with the paws or a bout of several wipes; forelimb ﬂails,
shaking of the forelimb; head shaking; paw treading, planting of the
limbs on the ﬂoor and alternating forceful strikes forward and
backward; and rapid locomotion around the chamber. This taste
reactivity analysis components and classiﬁcation has been previously
used [53,54].
The behaviors were counted each time they occurred as a single
event and were considered as discrete events in accordance with
previous studies [36,55]. Videotapes were scored in a slow motion
analysis at l/30 to 1/l0 normal speed. The means for ingestive,
rejection or neutral score were computed for each group. The
ingestive and rejection scores were independently analyzed, since
they represent phenomenological different categories of behavior.
2.6. Histology
At the end of the tests, the animals received bilateral injections of
2% Evans blue solution (0.2 μl) into the LPBN. They were deeply
anesthetized with sodium thiopental (80 mg/kg) and perfused
transcardially with 0.9% NaCl followed by 10% formalin. The brains
were removed, ﬁxed in 10% formalin, frozen, cut in 50-μm sections,
stained with cresyl violet, and analyzed by light microscopy to
conﬁrm the injection sites in the LPBN.
2.7. Statistical analysis
The results are reported as means±SEM. One-way analysis of
variance (ANOVA) or two-way repeated-measures ANOVA (using
treatment and time as factors), followed by Student Newman Keuls
tests were used for comparisons of the results from experiments 1 and
2, respectively. Differences were considered signiﬁcant at Pb0.05.
3. Results
3.1. Experiment 1 — taste reactivity to 0.3 M NaCl by rats treated with sc
FURO+CAP that received moxonidine injections into the LPBN
The FURO+CAP treatment combined with vehicle injected into
the LPBN increased ingestive [F(3,28)=4.5; pb0.05] and decreased
rejection behaviors [F(3,28)=8.2; pb0.05] to IO 0.3 M NaCl when
compared to control treatment (vehicle+saline sc combined with
vehicle into the LPBN) (Fig. 1). Bilateral injections of moxonidine
(0.5 nmol/0.2 μl) into the LPBN did not change these responses in rats
with no access to water and 0.3 M NaCl (Fig. 1).
3.2. Experiment 2 — taste reactivity to 0.3 M NaCl by FURO+CAP
treated rats that received LPBN moxonidine injections and had free
access to water and 0.3 M NaCl
As previously demonstrated, bilateral injections of moxonidine
(0.5 nmol/0.2 μl) into the LPBN increased FURO+CAP-induced 0.3 M
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intake [F(1,24)=2.2; pN0.05] (Fig. 2).
In rats treated with FURO+CAP sc, moxonidine injected into the
LPBN enhanced ingestive reactions at 30 and 60 min after free access
to water and 0.3 M NaCl intake [F(1,24)=13.2; pb0.05] (Fig. 3A), and
decreased rejection responses at 15, 30 and 60 min after free access to
water and 0.3 M NaCl intake [F(1,24)=20.2; pb0.05] (Fig. 3B).
Most of the LPBN injections were centered in the central lateral
and dorsal lateral portions of the LPBN (Fig. 4). Injections also reached
the ventral lateral and external lateral portions of the LPBN, and in
some rats the caudal parts of the Kölliker–Fuse nucleus. The LPBN
injection sites in the present study were similar to those of previous
studies that showed the effects of moxonidine on NaCl and water
intake [24,33,38,39].Time (min)
Fig. 2. Cumulative A) 0.3 M NaCl and B) water and intake by rats receiving taste
reactivity tests to 0.3 M NaCl after treatment with sc furosemide+captopril combined
with bilateral injections of vehicle or moxonidine (0.5 nmol/0.2 μl) into the LPBN.
Results expressed as means±SEM. n = number of animals.4. Discussion
Both LPBN vehicle and LPBN moxonidine treated animals showed
enhanced ingestive responses and decreased rejection responses after
FURO+CAP treatment before the access to water and NaCl solution.
As compared to LPBN vehicle injections, LPBN moxonidine treatment
did not affect either ingestive responses or rejection responses in
sodium and water depleted rats before the rats consumed any water
or 0.3 M NaCl. However, in comparison to LPBN treated vehicle
controls, LPBN moxonidine treated rats continued to show enhanced
ingestive reactions and reduced rejection responses even after
consuming large volumes of 0.3 M NaCl and water. In other words,
LPBN moxonidine treatment appears to block the satiation related
declines in ingestive responses or increase in rejection responses that
normally occur over the course of 0.3 M NaCl and water consumption.
The increase in ingestive and the decrease in rejection reactions to
0.3 M NaCl in FURO+CAP treated rats is consistent with previous
results demonstrating that animals with experimentally-induced salt
appetite show enhanced ingestive and reduced rejection oro-facial
and body behaviors [40,41]. In these previous experiments where
sodium depletion was induced by furosemide followed by 18 to 24 h
of restricted dietary sodium, rats showed comparable increased
ingestive and decreased rejection responding to IO hypertonic NaCl
solution [40,41]. In the present studies Experiment 1 showed that
FURO+CAP treatment, which induces a rapid onset of sodium
appetite, elicits increased ingestive behaviors and decreased rejectionreactions to IO hypertonic NaCl and that this occurred regardless of
whether animals received LPBN vehicle or moxonidine treatment.
Interestingly the results from experiment 1 indicated that LPBN
moxonidine treatment failed to enhance ingestive behaviors or
decrease rejection responses to IO 0.3 M NaCl beyond those changes
seen in LPBN vehicle treated rats. In light of this outcome, we
considered that this outcome might reﬂect a ceiling effect for
ingestive responses and/or a ﬂoor effect for rejection responses.
Therefore, we conducted a second experiment to test taste reactivity
to IO 0.3 M NaCl in FURO+CAP treated rats after ﬁxed periods of
0.3 M NaCl and water consumption. In the second experiment rats
with LPBN vehicle treatment showed a progressive reduction in
ingestive responses and an increase in rejection behaviors over the
course of a 1 h test period. In contrast rats with LPBN moxonidine
injections maintained a high level of ingestive responses and a low
level of rejection reactions to 0.3 M NaCl throughout the entire course
of the 60 min test period of free access to water and sodium. In
comparison to animals treated with LPBN vehicle injections, mox-
onidine maintained signiﬁcantly increased ingestive reactions and
reduced rejection responses in spite of ingesting signiﬁcant amounts
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Fig. 4. Photomicrograph of a transverse brain section from an animal representative of
the group tested showing the bilateral injection sites in the lateral parabrachial nuclei
(arrows). scp, superior cerebellar peduncle (outlined).
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possibly reduces some type of inhibitory signals produced as a
consequence of the ingestion of NaCl and water. An obvious
consequence of blocking such inhibitory mechanisms would be to
increase hypertonic NaCl intake in free access tests (i.e., to produce an
enhanced salt appetite, as deﬁned by increased hypertonic NaCl
solution ingestion). Of course rats treated with FURO+CAP combined
with LPBN moxonidine injections, stop the ingestion of hypertonic
0.3 M NaCl eventually, but this is likely to be the result of either a
reduction of the action of moxonidine in the LPBN or due to stronger
inhibition generated by the large quantity of NaCl and water ingested.
Previous studies have found that visceral inhibitory feedback
affects NaCl intake in rats [56–60]. For example, Krause and colleagues
[57] demonstrated the importance of post-ingestive signals for the
satiation of salt appetite and thirst in rats treated with FURO and
instrumented with gastric ﬁstulas to allow sham drinking. These
investigators found that when the ﬁstulas were open, saline andwater
intakes were signiﬁcantly increased as compared to that of closed
ﬁstula controls. In a similar vein, Flynn et al. [58] have found that the
increased intake of hypertonic NaCl observed in spontaneously
hypertensive rats (SHR) in comparison to normotensive Wistar
Kyoto (WKY) rats is associated with a decrease in the decline in lick
rate over the course of saline access in the SHR as compared to WKY
rats. These investigators suggested that the reduced decline in lick
rate evidenced by SHR may be because this strain is less responsive to
ingestion-contingent inhibitory feedback [58].
Evidence indicates that interactions between taste input and
inhibitory gastrointestinal, osmotic and vascular (e.g., arterial and low
pressure baroreceptor) signals may act to limit excessive salt and
water consumption. Information generated in the periphery is likely
to inﬂuence activity at one ormore central nervous system (CNS) sites
where input from gustatory and various visceral sensory systems
converge. The parabrachial nucleus is potentially one of these places.
Sodium taste information arrives in the CNS through the facial
nerve (VII) that innervates the anterior tongue [42]. Fibers from the
chorda tympani branch of the facial nerve terminate in the rostral
portion of the nucleus of the solitary tract (rNTS). In turn, the rNTS
sends ascending projections to the PBN. From the PBN, signals ascend
to a thalamic relay, the parvocellular ventral posteromedial thalamic
nucleus (VPMpc), [18,36,43]. Lesions placed in the NTS, PBN, or
VPMpc disrupt the shift in taste reactivity observed in intact animals
after sodium deﬁciency. However, only lesions in the NTS and PBN
block increases in home-cage intake observed after intact animals
were made sodium deﬁcient [36]. Flynn and colleagues (36) showed
that the PBN, the second synaptic relay of the ascending sodium taste
information in rats, is also important for the taste reactivity to sodium
in states of sodium deﬁcit.
As sodium is consumed, neural and humoral post-ingestive signals
fromthe gutandblood aredetectedbyneurons in the caudalNTSandAP
(see [44] for review). Viscerosensory afferent ﬁbers in the vagus nerve
are stimulated by gut distention (proportional to the volumeof ingested
ﬂuid), by luminal hyperosmolarity (due to the hypertonicity of NaCl),
and probably also by sodium-speciﬁc sensors within the portal
vasculature as sodium is absorbed [45]. These activated vagal afferents
stimulate neurons in theNTS aswell as cells in theAP, someofwhichcan
directly monitor humoral variables such as plasma osmolarity.
The region of AP/mNTS also receives afferent projections from
volume receptors (arterial baroreceptors and cardiopulmonary re-
ceptors), and these receptors can inﬂuence the ingestion of water and
sodium [22,23,46,47]. Activation of superior vena cava–right atrial
junction receptors has been shown to attenuate isoproterenol-
induced water intake in intact rats, and this inhibition is abolished
by electrolytic lesions of the LPBN [48]. These ﬁndings support the
hypothesis that the LPBN is involved in the inhibition of drinking
mediated by volume receptor stimulation. Many neurons in the
caudal or medial NTS and AP project to nuclei within the LPBN [13]. In
707C.A.F. Andrade et al. / Physiology & Behavior 104 (2011) 702–708turn, neurons in these LPBN nuclei transmit this information to a
variety of limbic and hypothalamic targets in the forebrain [49,50],
providing negative feedback signals that inhibit ingestive behaviors
[7,10,22,23,33,38,51,52].
In summary, the present results demonstrate that moxonidine
injections into the LPBN change the pattern of taste reactivity to 0.3 M
NaCl by maintaining ingestive reactions, and reducing rejection
responses after free access to water and 0.3 M NaCl intake. Therefore,
the present results suggest that LPBN moxonidine injections reduce
inhibitory signals activated as a consequence of the ingestion of
hypertonic NaCl solution and water.
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